France · Source-listed medicine information
France / CIS 66118412
GLUCOSE FRESENIUS 5 %, solution pour perfusion
solution pour perfusion · intraveineuse
Source data retrieved: 2026-09-17. Clinical review is not yet available.
Product identity
At a glance
- Authorisation holder
- FRESENIUS KABI FRANCE
- Authorisation status
- Autorisation active
- Market status
- Commercialisée
- Country
- France
- Source reference
- CIS 66118412
Reported market status does not confirm current pharmacy stock.
From the official composition record
Ingredients & strength
Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.
| Ingredient | Strength / reference | Source role |
|---|---|---|
| GLUCOSE ANHYDREsolution | 5,00 g100 ml de solution pour perfusion | FTGroup 1 |
| GLUCOSE MONOHYDRATÉsolution | 5,50 g100 ml de solution pour perfusion | SAGroup 1 |
Pack references
Presentations (10)
CIP13 3400936762640
Présentation active · Déclaration de commercialisationCIP13 3400936762701
Présentation active · Déclaration de commercialisationCIP13 3400936762879
Présentation active · Déclaration de commercialisationCIP13 3400936762930
Présentation active · Déclaration de commercialisationCIP13 3400936763012
Présentation active · Déclaration de commercialisationCIP13 3400941572241
Présentation active · Déclaration de commercialisationCIP13 3400941572302
Présentation active · Déclaration de commercialisationCIP13 3400941572470
Présentation active · Déclaration de commercialisationCIP13 3400941572531
Présentation active · Déclaration de commercialisationCIP13 3400941572760
Présentation active · Déclaration de commercialisationFrom the French medicines authority
Official documents
The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.
Open the official product entryBDPM · CIS 66118412 · Opens in a new tabCheck the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.
Where this information comes from
Sources & dates
Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.
| Source file | Retrieved | Source file modified |
|---|---|---|
| fr_products.txt | Not supplied | |
| fr_composition.txt | Not supplied | |
| fr_packs.txt | Not supplied |
Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.
Our sources and review process →